I am often asked by industry colleagues that if I had to pick just one “favorite” federal regulation what would it be? The answer is easily 21 CFR 812.100, as this regulation embodies 95% of the investigational site non-compliances I observe as I conduct clinical investigator audits. Let me elaborate.
Topics: 21CFR812.100, Investigator Responsibilities, Clinical Auditing, FDA, Clinical Research

